Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of Sollpura
Feb 05, 2018 13:30 pm UTC| Business
HAYWARD, Calif., Feb. 05, 2018 -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) is pleased to announce that the final patient has completed the last visit in the primary treatment phase of RESULT, a Phase 3 clinical study...
Full House Resorts Announces $100 Million Refinancing of Its Debt
Feb 05, 2018 13:30 pm UTC| Business
- Company expects approximately $1.1 million of annual interest savings based on current interest rates - New six-year senior secured note extends debt maturity dates from 2019 to 2024 - Replaces all of the Company’s...
Retail TouchPoints 2018 Retail Innovator Awards Nomination Deadline Extended
Feb 05, 2018 13:30 pm UTC| Business
HASBROUCK HEIGHTS, N.J., Feb. 05, 2018 -- Retail TouchPoints, the industry’s go-to source for the latest retail trends, strategies and technology innovation, has announced that the deadline to submit nominations for the...
Celebrate Love at 425° this Valentine’s Day with Papa Murphy’s HeartBaker® Pizza
Feb 05, 2018 13:30 pm UTC| Business
VANCOUVER, Wash., Feb. 05, 2018 -- Papa Murphy’s Holdings, Inc. (NASDAQ:FRSH) is pleased to announce the return of its Valentine’s Day favorite, the HeartBaker® Pizza. The festive pizza is shaped like a heart and is...
Progenics Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference
Feb 05, 2018 13:30 pm UTC| Business
NEW YORK, Feb. 05, 2018 -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced today that Patrick...
EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery
Feb 05, 2018 13:30 pm UTC| Business
WALTHAM, Mass., Feb. 05, 2018 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating...
Feb 05, 2018 13:30 pm UTC| Business
Company appoints new VPs of Clinical Science, Manufacturing, and Finance and hires new Senior Director of Marketing New hires support Acer’s progression from development to potential commercialization of EDSIVOTM ...